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ABSTRACT 
 
Menstrual Cycle Effects on Pain Modulation and  
Autonomic Arousal. (August 2006) 
Jeffrey Scott Grimes, B.S., Louisiana State University;   
M.S., Texas A&M University 
Chair of Advisory Committee:  Dr. Mary Meagher  
 
Animal research has elucidated the neurobiological substrates and environmental 
determinants of pain modulation.  Despite these advances, relatively little is known 
about how psychological processes activate pain modulatory systems.  One 
psychological process that is thought to play an important role in regulating pain 
sensitivity is emotion.  In addition, previous research into the human menstrual cycle and 
the animal estrous cycle have determined that either the presence of certain gonadal 
hormones or the fluctuations of these hormones may lead to changes in how females 
perceive pain, regulate emotion, and modulate pain.  The present study examines both 
the role of emotion and the human menstrual cycle in pain modulation.  Participants 
were 39 female undergraduate students with a mean age of 18.7 years (SD=1.46).   
Results are consistent with prior studies indicating that progesterone has anti-
inflammatory effects.  Specifically, significant effects were observed primarily in the 
luteal phase.  Subjects in the luteal phase demonstrated less sympathetic arousal during 
the experiment but greater autonomic arousal during the noise stressor.  Participants in 
the luteal phase also demonstrated an analgesic/anti-inflammatory response evidenced 
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by an observed decrease in secondary hyperalgesia for those that did not receive the 
noise stressor.  No such changes in pain perception were discovered in the ovulation 
and follicular phases.  Finally, in response to the noise stressor, an inhibition of the 
analgesic/anti-inflammatory effects was observed in the luteal phase.  No such 
evidence of stress-induced pain modulation was discovered in the ovulation and 
follicular phases.  Although the specific mechanisms of this action still remain unclear, 
prior evidence points to the role of centrally-mediated pain modulation. It is likely that 
the stressor worked to inhibit the anti-inflammatory effects commonly observed in the 
luteal phase to persistent inflammatory pain through centrally-mediated pain 
modulatory mechanisms.  It is hypothesized that hormone-mediated effects at the level 
of the amygdala influenced the impact of affective pain modulation.   
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INTRODUCTION 
Animal research has elucidated the neurobiological substrates and environmental 
determinants of pain modulation.  Despite these advances, relatively little is known 
about how psychological processes activate pain modulatory systems.  One 
psychological process that is thought to play an important role in regulating pain 
sensitivity is emotion.  In addition, previous research into the human menstrual cycle and 
the animal estrous cycle have determined that either the presence of certain gonadal 
hormones or the fluctuations of these hormones may lead to changes in how females 
perceive pain, regulate emotion, and modulate pain.  Hence, the present study hopes to 
examine both the role of emotion and the human menstrual cycle in pain modulation. 
Sex Hormones in Pain 
Previous animal research has demonstrated increased variability in the pain 
perception of females when compared to males with most studies demonstrating that 
females are more sensitive to pain than males (Romero & Bodnar, 1986; Romero et al., 
1988).  It is assumed that much of the sex difference is due to the modulatory influence 
of gonadal hormones.  In fact, many studies have demonstrated that when 
ovariectomized rats are administered estrogen they display increased pain sensitivity, but 
when both progesterone and estrogen are administered, analgesia is observed (Drury & 
Gold, 1978; Martinez-Gomez et al., 1994; Ratka & Simpkins, 1991; Ryan & Maier, 
1988).  Researchers have also documented that pain sensitivity varies along the estrous  
_____________________ 
This dissertation follows the style of Pain. 
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cycle with most studies finding increased pain sensitivity during periods in the estrous 
cycle when estrogen peaks compared to periods where estrogen decreases and 
progesterone increases (e.g., Cason, Samuelson, Berkley, 2003; Kayser et al., 1996; 
Sapsed-Byrne et al., 1996).  Taken together, it appears that for the most part, estrogen 
has demonstrated a pro-nociceptive effect, but when progesterone is introduced greater 
analgesia is observed.     
As in the animal research, human studies have described differences in how the 
two genders perceive and respond to pain.  In general, most experimental human pain 
studies have demonstrated that women show greater pain sensitivity (Fillingim, 2003; 
Fillingim, Maixner, Kincaid, & Silva, 1998; Riley et al., 1999).  However, mixed 
findings have been reported in clinical pain studies with most studies reporting greater 
pain sensitivity in specific chronic pain syndromes, such as fibromyalgia, arthritis pain, 
and multiple sclerosis (e.g., Anderberg et al., 1999; Affleck et al., 1999; Keefe et al., 
2000, Warnell, 1991), while others report minimal gender differences in other chronic 
pain populations, such as cancer-related pain (Turk & Okifuji, 1999). 
Researchers have proposed several psychosocial, evolutionary, and biological 
hypotheses to help explain the observed gender difference in human pain.  Biologically, 
the focus of much of the research has been on the impact of gonadal hormones and/or 
the menstrual cycle on pain perception, however, much of the human research has not 
focused on the assessment of sex hormone levels in the body, but rather patient report of 
menstrual cycle (e.g., Amodei & Nelson-Gray, 1989; Hapidou & Rollman, 1998).  This 
methodology is problematic in that approximately 20% of cycles can be anmenstrual 
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(Girdler et al., 1993) and self-report relies solely on the presumption that cycles are not 
variable in length.  These studies have produced inconsistent findings when viewed on 
an individual basis, but when a meta-analytic procedure is utilized to correct for the 
problem of small sample size, effects by menstrual cycle emerge with menstrual and 
luteal phases producing greater pain sensitivity than follicular phases (Riley et al., 1999).    
Although much of the research has focused on the use of self-report, there have 
been some studies that quantify sex hormone levels using either ovulation predicting 
devices and/or plasma hormone levels.  Fillingim and colleagues (1997; 2000) have 
shown that women demonstrate decreased pain tolerance to ischemic pain in their luteal 
phases versus follicular phases.  In examining thermal pain sensitivity, the researchers 
did not find any effects by menstrual cycle.  However, they did find that regardless of 
menstrual cycle phase, periods of higher estrogen levels predicted higher thermal pain 
sensitivity.  In addition, to assessing the level of hormone, studies have also examined 
the use of estrogen-replacement therapies and pain response.  In general, the research has 
demonstrated that the use of exogenous estrogen is correlated with increased risk of 
specific pain disorders and associated symptoms, such as temporomandibular disorders 
(LeResche et al., 1997) and back pain (Musgrave, Vogt, Nevitt, & Cauley, 2001).  Oral 
contraception use has also been examined with typical findings purporting that oral 
contraception leads to a decrease of the menstrual cycle effects found in pain perception 
(Hapidou & Rollman, 1998; Thompson et al., 1997). 
 
 
4 
   
 
Sex Hormones in Inflammation 
Studies examining the role of sex hormones in inflammatory responses to tonic 
pain models (i.e., carageenan, formalin) have found progesterone to attenuate 
inflammatory responses (Ren et al., 2000; Ji et al., 2005, Nakagawa et al., 1979, Uchida 
et al., 2003, Kuba et al., 2006).  For example, Ren and colleagues (2000) found that 
during lactation, female rats demonstrate an inhibition to persistent inflammatory 
hyperalgesia.  Because lactation is a period where progesterone levels are high and 
estradiol levels are low, it was concluded that progesterone produced the anti-
inflammatory/anti-nociceptive effect.  Furthermore, studies have also demonstrated that 
injected progesterone attenuates the pro-nocicieptive activity of estradiol in 
ovariectomized animals; however, progesterone alone does not (Ji et al., 2005, Kuba et 
al., 2006).  These finding suggest that although progesterone may have anti-nociceptive 
and anti-inflammatory effects, it does not produce these effects in isolation but rather 
through the interaction between either the simple presence or levels of estradiol and 
progesterone.         
In contrast, older studies examining the effects of sex hormones on the 
inflammatory process in wound healing have found that administration of estradiol to 
ovariectomized animals inhibits the inflammatory response associated with the first 
phase of wound healing (Taubenhaus & Amromin, 1949; Rigdon & Chrisman, 1941).  
More recently, Josefsson and colleagues (1992) also have observed that exogenous 
estradiol appears to have anti-inflammatory effects because it reduces foot swelling in 
ovariectomized animals.  Although not specific to the inflammatory phase of wound 
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healing, other studies have similarly demonstrated possible anti-inflammatory effects of 
estrogen in finding that estradiol reduces the concentration of polymorphonuclear 
leucocytes in humans (PMNLs; Ito et al., 1995; Miyagi et al., 1992).  This reduction in 
PMNLs has been shown to promote healing in the initial inflammatory phase.    
As in other areas of sex hormone research, definitive conclusions regarding the 
role of sex hormones in inflammation remain elusive.  Similar to other hormonal studies, 
a primary problem in understanding this research is that it utilizes the induction of 
excessive amounts of exogenous hormones into damaged animals.  One might ask, does 
simply the presence of estradiol inhibit the inflammatory response or does the sharp 
increase in level of estradiol produce inhibition?  It is difficult then, to understand the 
role of natural variations in sex hormones in the inflammatory response.        
Sex Hormones in Emotion 
 Similar to pain research, gender differences have long been observed in the 
presentation and regulation of emotion.  Clinically, researchers have documented that 
women are twice more likely than men to experience a mood disorder and women will 
experience longer and more severe episodes of mood disruption than men (Nolen-
Hoeksma, 1987).  The reasons for this gender difference, however, remain unclear.  In 
examining the biological mechanisms for this difference, most research has focused on 
the presence and fluctuation of gonadal hormones (Shors & Leuner, 2003).  In fact, 
Sonnenberg and colleagues (2000) found that after menopause, when the fluctuation and 
presence of gonadal hormones are significantly decreased, gender differences in mood 
disruption tend to lessen.  
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 In general, most of the evidence regarding mood disturbance and gonadal 
hormones is derived from clinical observation and epidemiological studies.  For 
instance, postpartum periods, menopause, premenstrual syndrome, and premenstrual 
dysphoric disorder are all highly correlated with increased levels of negative affect 
(Bloch, et al., 2000; Rubinow, 1992).  During these periods, women experience low 
levels of gonadal hormones and/or precipitous fluctuations in the level of these 
hormones.  It is thought that these hormones, especially estrogen, work to facilitate 
serotonergic systems and, in the absence of estrogen, women are more likely to develop 
mood disturbance (Belthea, et al., 1999).  Clinically, some studies have demonstrated the 
antidepressant effect of estrogen and/or the combination of estrogen and progesterone 
(Derman et al., 1995; Klaiber et al., 1996) while others have found that other factors, 
such as history of depression, were better predictors of mood disturbance then the use of 
exogenous estrogen (Bloch et al., 2000).   
 Learned helplessness paradigms have also been employed to examine the impact 
of gonadal hormones on aversive conditioning.  Although most studies have 
demonstrated that females do not demonstrate learned helplessness in the traditional 
paradigms (Kirk & Balmpied, 1985; Steenberben et al., 1990), Shors (1998; 2000), 
utilizing an eye-blink conditioning paradigm, has found a gender difference in 
associative learning after presentation of various stressors.  Specifically, males show 
facilitation in associative learning after presentation of stress while females show 
inhibition.  This effect is reversed with ovariectomy and exogenous presentation of 
estrogen antagonists (Woods & Shors, 1998).  Hence, this evidence suggests that the 
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presence of female sex hormones produces difficulty in the rat’s ability to learn 
avoidance strategies to aversive stimuli, which in humans could potentiate and maintain 
negative affective states. And although it appears that the presence of estrogen impairs 
aversive learning during the presence of stress, it is unclear whether it is simply the 
presence of estrogen or swift changes in estrogen that produce the impairment in 
learning.   
Sex Hormones in Pain Modulation 
Although much of the earlier animal research examining the circuitry of pain 
modulation focused primarily on males, more recent studies have begun to examine the 
role of pain modulation in females and how the presence and fluctuation of gonadal 
hormones can influence pain modulation.  Although the research remains unclear on the 
direction of pain modulation with some studies demonstrating that the presence of 
gonadal hormones increases (Banerjee et al., 1983), decreases (Kepler, et al., 1989; 
Krzanowska & Bodnar, 1999), or does not affect (Cicero et al., 1996; Kepler et al., 
1991) anti-nociception, as a whole, most animal studies demonstrate that periods in 
which estrogen is elevated either alone through exogenous hormone introduction or 
accompanied by corresponding elevations in progesterone either endogenously or 
exogenously are characterized by diminished analgesia (Fillingim & Ness 2000).   
It has been shown that pharmacological manipulations in which exogenous 
substances that either mimic the presence of estrogen or promote its release diminish the 
analgesic effect of morphine (Berglund et al., 1988; Berkley, 1997; Ratka & Simpkins, 
1991).  In addition, prenatal de-feminization and orchidectomy eliminate sex differences 
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in opioid analgesia (Cicero et al., 2002; Krzanowska et al., 2002).  Stress-induced 
hypoalgesia paradigms have demonstrated that female rats show both significantly less 
analgesia than male rats, as well as differences in the neural substrates that modulate this 
hypoalgesia (Kavaliers & Choleris, 1997; Kepler et al., 1989; Mogil & Belknap, 1997; 
Mogil et al., 1993).  These findings have led researchers to examine the role of estrogen 
in this form of pain modulation. These studies, however, have not always found 
consistent results with some studies finding no effect by estrous cycle (Romero & 
Bodnar, 1986) and others showing reduced opioid-mediated stress-induced hypoalgesia 
during phases of the estrous cycle that estrogen dominate (Ryan, & Maier, 1988).   
Furthermore, when ovariectomy is performed, females begin to demonstrate similar 
forms and levels of analgesia that males display.  This analgesia can later be eliminated 
via estrogen replacement therapy (Mogil et al., 1993).   
Although there is a history in the animal literature of examining gender 
differences in pain modulation, human research has not clearly demonstrated a 
consistent gender effect in pain modulation.  While some studies have found women to 
demonstrate greater analgesia to mu and kappa opioid agonists on tonic pain models 
when compared to men (Fillingim, 2002; Zacny, 2002), others demonstrate a lesser 
involvement of mu opioid receptor systems in women during low hormonal phases of 
the menstrual cycle compared to men (Zubieta et al., 2002).   It should be noted that 
although this latter study suggests greater activation of endogenous opioids in men, the 
authors did find greater mu opioid receptor availability in women.  Gender differences in 
affective pain modulation have also been observed with anger (Westcott & Horan, 1977) 
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and noise stress (Rhudy & Meagher, 2001) producing hypoalgesic pain responses in 
women when compared to men and anxiety manipulations (Dougher et al., 1987) 
producing hyperalgesic pain responses when compared to men.    
Pain Modulation in an Inflammatory Pain Model 
Previous human research has been instrumental in determining the role of 
emotion in pain modulation using acute pain models (Janssen & Arntz, 1996; Johnson & 
Helmstetter, 1994; Rhudy & Meagher, 2000; Willer & Albe-Fessard, 1980; Willer, 
Dehen, & Cambier, 1981; Willer & Ernst, 1986).  Unfortunately, acute pain models may 
not generalize well to common clinical pain syndromes that are chronic or inflammatory 
in nature and to better generalize these experimental effects of pain modulation to 
clinical pain, new experimental models are needed.  The use of capsaicin, which is an 
ingredient of hot peppers, has shown promise in modeling neuropathic and inflammatory 
clinical pain (i.e., Ali, Meyer, & Campbell, 1996; Fuchs, Campbell, & Meyer, 2000; 
Magerl, Wilk, & Treede, 1998; Raja, Campbell, & Meyer, 1984).  A principal benefit of 
using a capsaicin pain model to study hyperalgesia is that it provides a means of 
studying both primary and secondary hyperalgesia, which are triggered by different 
neural mechanisms.  
Primary hyperalgesia is characterized by spontaneous pain and both heat and 
mechanical hyperalgesia (Raja, Campbell, & Meyer, 1984).  In addition, it is likely the 
result of activation and sensitization of both peripheral and central nociceptors (Raja, 
Campbell, & Meyer, 1984; Torebjork, Lundberg, & LaMotte, 1992).  In contrast, 
secondary hyperalgesia is characterized by only mechanical (static, dynamic, and 
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punctate) hyperalgesia (Ali, Meyer, & Campbell, 1996; Fuchs, Campbell, & Meyer, 
2000; Magerl, Wilk, & Treede, 1998; Raja, Campbell, & Meyer, 1984).  Furthermore, 
secondary hyperalgesia is caused by the sensitization of central nociceptive neurons 
(Campbell, Khan, Meyer, & Raja, 1988; Torebjork, Lundberg, & LaMotte, 1992).  The 
central mediation of secondary hyperalgesia is supported by the finding that hyperalgesia 
can be evoked by stimulation of afferent fibers even after peripheral nociceptors have 
been anesthetized (Torebjork, Lundberg, & LaMotte, 1992).   
Although most of the research using the capsaicin model has concentrated on 
deciphering the neural mechanisms of hyperalgesia, Lutgendorf, Logan, and colleagues 
(2000) examined the effects of relaxation and stress on capsaicin-induced inflammation. 
Relaxation training reduced flare size relative to control, but their experimental mental 
stress task (Stroop color-word test) did not.  However, individual differences in 
sympathetic arousal (serum norepinephrine, heart rate, and systolic blood pressure) 
during the stressful experimental task predicted increased flare size, suggesting that 
stress-induced increases in sympathetic outflow modulated flare size.   In a recent 
follow-up study, Logan and colleagues (2001) presented findings on capsaicin-related 
pain.  Similar to their previous study, they examined the effects of relaxation and stress, 
finding that relaxation reduced ratings of spontaneous pain, whereas stress increased 
pain in women. Unfortunately, this study did not determine whether stress level altered 
primary or secondary hyperalgesia.    
In addition, other studies have shown that pharmacological manipulations of the 
peripheral noradrenergic system alter capsaicin-induced thermal hyperalgesia, with 
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agonists causing enhanced pain and antagonists reducing it.  For example, Drummond 
(1995) has shown that pharmacological activation of peripheral noradrenergic receptors 
potentiates thermal hyperalgesia; however, this NE manipulation does not activate the 
sympathetic-adrenal medullary system, but rather is only a model for the NE release 
produced by stress-induced sympathetic-adrenal medullary excitation. 
Other studies implicate central pain modulatory mechanisms in the capsaicin 
pain model.  Evidence for descending modulation of capsaicin pain comes from Witting 
and colleagues (1998) who reported that capsaicin-induced pain and allodynia are 
reduced by exposure to painful heterotopic stimulation (e.g., immersion of foot in cold 
water), an effect known as diffuse noxious inhibitory control (DNIC).  DNIC appears to 
be mediated by the activation of a spinal-supraspinal-spinal feedback loop.  In light of 
these findings, it seems plausible that emotion-induced activation of descending pain 
modulatory pathways could influence spinal processes of central sensitization or 
neurogenic inflammation.   
Previously, our laboratory (Grimes et al., 2003; 2004) set out to further study the 
role of affective pain modulation on capsaicin-induced pain by examining the impact of 
noise stress on both primary and secondary hyperalgesia.  Men and women both 
perceived the noise stressor as unpleasant and stressful.  The noise stressor significantly 
altered secondary hyperalgesia by increasing the area of allodynia in men and in women.  
Although the noise stressor did show a significantly greater pain modulatory effect 
(hyperalgesia) in stressed men than unstressed men, women in the stress condition did 
not show any significant pain modulatory effect when compared to women in the no 
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stress condition, but did show a slowing of the inhibition of capsaicin-induced tactile 
pain.  A gender effect for spontaneous pain emerged with women experiencing the 
capsaicin as much more intense and unpleasant than men.  
The present study further examines the modulatory impact of stress on 
inflammatory pain in women by controlling for the role of sex hormones.  In controlling 
for the menstrual cycle we hope to provide evidence that, similar to previous animal 
research, the sex hormones are integral in both female pain perception and affective pain 
modulation.  This is an extremely important question clinically in that there are 
numerous pain disorders that are significantly more prevalent in women than in men 
(Riley et al., 1999; Fillingim & Ness, 2000) and much of the treatment for these 
disorders do not take into account the possibility of alternate female-dependent pain 
modulatory pathways, such as an estrogen-dependent pain modulatory pathway.  
Furthermore, this study is unique in that we are examining the role of endogenous, 
normally fluctuating sex hormones in pain modulation.   It is hypothesized that natural 
fluctuations in hormones, especially phases that are characterized by greater fluctuations 
in hormones (ovulation and luteal), will influence both pain perception as well as pain 
modulation.  According to the literature, it is thought that women in the ovulation phase 
will demonstrate greater pain sensitivity, and less pain modulation.  Given the propensity 
of sensitivity to negative affect, it is thought that the luteal phase will demonstrate the 
greatest degree of affective pain modulation.  
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METHODS 
Participants 
  Participants were 106 female undergraduate psychology students who received 
course credit for their participation. Of these 106 subjects, 58 failed to schedule DAY 2 
pain testing.  Of the remaining 48 subjects, 2 subjects withdrew from the study during 
DAY 2 experimentation and 4 subjects were dismissed during DAY 2 testing because of 
equipment malfunction.  In addition, 3 subjects were removed from the analyses because 
they reported not experiencing any pain to the tactile pain tests.  Final analyses included 
39 subjects, 87% were Caucasian, 5% Hispanic, 3% African-American, and 5% other.   
Mean age was 18.7 years (SD=1.46).  Persons were excluded for: circulatory, 
cardiovascular, or neurological problems; chronic pain; or tobacco, analgesic, anti-
histamine, anti-depressant, anti-inflammatory, hormonal birth control, or recent 
drug/alcohol use.   
Apparatus 
To assess the participants’ menstrual phase, an OvuLens (Craig Medical 
Distribution) saliva fertility prediction microscope was used.  Participants were 
instructed on the proper use of the device, which consists of placing a saliva sample on 
the internal slide and focusing the microscope on the slide.  When the estrogen level 
increases near the participants’ ovulation period, the dried electrolyte crystals in the 
saliva form a fern-like pattern.  When this fern-like pattern appeared, participants 
scheduled an appointment to complete Day 2 of the experiment.  The appointment time 
was dependent on their placement in an menstrual phase (ovulation, luteal).  Participants 
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in the follicular phase were scheduled appointments based on report that they completed 
their menstruation.   
Skin conductance (SCL) was recorded via 2 velcro sensors (Grass F-EGSR) 
attached to the palmar surface of the middle digits on the index and middle fingers of the 
non-dominant hand.  Heart rate (HR) was measured using a Grass Instruments pulse 
transducer (Grass PPS) attached to the distal digit of the index finger of the non-
dominant hand.  All physiological data were collected using a Grass Instruments Model 
7E Polygraph using Model 7DA driver amplifiers, preamplifiers were Model 7P8 and 
Model 7P1 for both skin conductance and heart rate.  Skin conductance and heart rate 
were sampled at 50 Hz.   All stimulus control and data acquisition was computer 
regulated by LabVIEW software and an AT-MIO-16DL DAQ board (both by National 
Instruments).   
A mechanical visual analog scale was used to measure pain reactivity.  The 
device consists of a sliding potentiometer, which is an electronic component that allows 
a user to adjust the resistance (i.e., similar to a volume knob).  Labels were affixed to the 
device with the anchors “No Pain” and “The Most Intense Pain Imaginable”.  Because 
there is a nonlinear relationship between voltage output and position of the 
potentiometer slide, all recorded voltages were later transformed from nonlinear to linear 
scales with the use of a mathematically derived logarithmic function.  This logarithmic 
transformation creates a linear visual analog scale with points ranging from 0 “No Pain” 
to 10 “The Most Intense Pain Imaginable”.        
15 
   
 
 The noise stressor consisted of bursts of white noise (105 db) against a 
background of white noise (60 db).  The noises were generated using Cool Edit software 
(Syntrillium Software Corp, Phoenix, AZ).  A computer controlled the noises by 
triggering a relay connecting the signal from a cassette deck to the subject’s headphones.  
Six noises were presented at pseudorandom intervals (3-sec to 1-min) and durations 
(0.75 to 10-sec) over a 2-min period.  
Measures 
Self-Report 
 To examine the presence of any medical problem or the use of 
medication/substance that may impact pain perception and inflammation, a health status 
questionnaire was presented to participants.  The questionnaire inquired about 
demographic information, their current use of any medications, including hormonal birth 
control, and the presence of any medical abnormality/illness that may potentially impact 
pain perception or inflammation.  Furthermore, because we are interested in the effects 
of stress on pain reactivity, it is necessary to assess any preexisting emotional distress 
that may contribute to unwanted group differences.  To do so, the Center for 
Epidemiological Studies-Depression Scale (CES-D; Radloff, 1977), a brief, 20-item 
questionnaire that taps into depression and anxiety symptoms was filled out prior to the 
experiment.  Subjects were instructed to read each item and rate the extent to which they 
felt that way at sometime during the past week.       
To assess the emotional impact of the noise stressor, participants filled out two 
questionnaires at the end of the experiment.  The Self-Assessment Manikin (SAM; Lang, 
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1980) is a measure with two pictogram scales indicating various levels of valence 
(ranging from “happy” to “unhappy”) and arousal (ranging from “excited” to “calm”).  
Participants were asked to place an “X” on or between any of the figures to indicate their 
emotional response to their treatment condition:  the unpredictable bursts of noise 
(Stress) or being told that they would not receive unpredictable shocks (No Stress).  
Participants also rated their emotional reaction on 5-point Likert scales that ranged from 
“not at all” to “strongly” for ten affective descriptors (angry, disgusted, fearful, happy, 
sad, surprised, neutral, anxious, bored, and relaxed).  
 To evaluate whether subjects were aware of our hypothesis, subjects were given 
an exit questionnaire asking them what they believed the experiment was designed to 
investigate.  Subjects that gave answers indicating that they understood the hypothesis 
and purpose of the study were excluded.  In addition, the exit questionnaire consisted of 
a number of open-ended questions regarding their feelings toward the experiment, noise 
stressor, and the spontaneous pain from the topical capsaicin.     
Physiological Indicators 
To assess the impact of the psychophysiological effects of our affective 
manipulation, heart rate (HR) and skin conductance level (SCL) were recorded.  It was 
sampled for 1-min prior to each pain test, as well as 1-min prior to capsaicin induction 
and for the entirety of the 2-min noise stress period.  Examinations of skin conductance 
were performed with tonic levels of skin conductance during the recording periods.  
Heart rate was examined in 5-sec blocks of time and represent beats per minute (BPM).       
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Procedure 
On DAY 1, all subjects met in the experiment room where an experimenter read 
aloud the requirements, details, and instructions of the experiment.  Subjects filled out 
the informed consent, demographics, a health status questionnaire, and CES-D.  The 
experimenter then presented the subjects with the OvuLens device and instructed them 
on its use.  No pain testing occurred on DAY 1.  Contact information was exchanged.  
Subjects were told to contact the laboratory both when they viewed a positive fern 
pattern on the OvuLens device and after they completed their menstruation.  During 
DAY 1, subjects were placed in either the Stress or No Stress condition and it was 
decided during which phase (Ovulation, Luteal, Follicular) the subject would be asked to 
return for DAY 2 pain testing.  For those in the Ovulation phase, subjects were asked to 
return to the lab for DAY 2 pain testing 1-to-3 days after observing a positive fern 
pattern; subjects in the Luteal phase were asked to return 5-to-10 days after observing a 
positive fern pattern; and subjects in the follicular phase were asked to return within 10 
days after finishing their menstruation.        
On DAY 2, subjects brought the OvuLens device to the laboratory to ensure that 
the positive fern pattern was read correctly.  If read correctly, the participant’s informed 
consent, health status, and pre-existing level of distress were again reviewed.  Subjects 
were then presented with procedural information and instructed on the required 
experimental tasks (i.e., rating their emotional reactions and pain reactivity).  To ensure 
that subjects were able to rate changes in pain consistently, a cross-modality practice 
trial was employed where subjects were asked to practice rating changes in perceived 
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pressure being applied to their arm via a blood pressure cuff using the VAS device.  The 
cuff was inflated to 100, then 200, then back to 100, and finally the pressure was brought 
back to 0.  Proficiency in this task suggests that the subject will be likely to generate 
consistent pain ratings over time.  After the practice, heart rate and skin conductance 
sensors were applied to their fingers.  A grid with eight spokes radiating from the center 
was drawn in the center of their dominant volar forearm (Figure 1) with each spoke 
consisting of ten pain application sites.  The subject was then given final instructions and 
questions regarding the procedures were fielded.  A curtain is drawn and the subject’s 
dominant forearm is placed on the experimenter’s side of the curtain.  The curtain is 
required to ensure that the participants are not receiving visual clues of inflammatory 
status or level of pain reactivity from the von Frey hair, which could impact pain ratings. 
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Site of Testing 
 
PRIMARY 
SITE 
SECONDARY 
SITE 
ELBOW 
WRIST 
 
8 radial 
pathways were 
used to assess the 
size of the 
secondary 
hyperalgesic 
zone 
 
 
 
 
 
 
 
 
Figure 1: Site of Testing. Testing began outside the area of secondary 
hyperalgesia and worked inwards toward the primary inflammatory site.  
Testing began at the wrist and was completed in a clockwise fashion.    
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Figure 2 illustrates the experimental procedure, specifically when pain tests, 
capsaicin, and noise stressors were presented as well as when psychophysiological data 
were recorded.  To begin, subjects underwent a practice pain test in which a large 
diameter von Frey hair (6.65 g) was applied to each pain site along the spokes.  The 
experimenter began on the wrist spoke, where all ten sites on each spoke were stimulated 
working from the outside in.  After each spoke, the VAS device was brought back down 
to zero and the next clockwise spoke was stimulated.  All pain tests were conducted in 
the same manner.  Following the practice pain test, 300 µl of a 6.0% capsaicin solution 
was topically applied to the dominant volar forearm via a 1.5 cm x 1.5 cm gauze pad 
(Culp et al., 1989; Simone, Baumann, & LaMotte, 1989).  To impede evaporation, the 
site of application was covered with a dressing (Baron et al., 1999).  The pad and 
dressing was left on the arm for a period of 25-min.  During this time, subjects were 
asked to rate their emotion using a SAM and a set of affective descriptors at 5-min 
intervals.  Subjects were also asked to rate their pain at these 5-min intervals using a 
VAS, which contain both an “intensity” and an “unpleasantness” component.   
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DAY 2  
Experimental Procedure 
Figure 2: Experimental procedure for Day 2.  Bars above the matrix indicate times that physiological data 
were recorded. Physiological data were recorded 1 min prior to every trial, as well as during the noise stress 
manipulation.  
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Since variability in skin temperature has been shown to introduce variance in studies 
using a capsaicin manipulation, skin temperature was regulated throughout the 
experiment to ensure that temperature at the inflammatory site remained 36 degrees 
Celsius (Liu et al., 1998).  
After capsaicin induction, the capsaicin was removed from the forearm and 
subjects underwent a pain trial, as described earlier.  Subjects were then randomly placed 
into a stress condition (Stress or No Stress).  During the Stress conditions subjects were 
told, “they may or may not be presented with brief, loud, surprising bursts of noise” and 
presented with pseudorandom bursts of white noise (105 db) against a background of 60 
db white noise.  The affect manipulation took place over a 2-min period.   Those in the 
No Stress condition were told, “they would not receive the brief, loud bursts of noise”.  
After the affect manipulation phase, subjects then underwent a retest pain trial.  At the 
conclusion of the Day’s experiment, subjects were asked to rate their emotional reactions 
to either the bursts of noise or being told that they would not receive the noise.  Finally, 
subjects were also given an exit questionnaire and were debriefed. 
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RESULTS 
Manipulation Checks 
Pre-existing Distress 
 To examine the presence of any pre-existing levels of emotional distress, CES-D 
scores were analyzed using a one-way ANOVA with Phase as a between-group variable.  
No significant group differences were found for CES-D scores [F(2, 37) = .95, MSE = 
37.42, p > 0.05].  This result suggests that regardless of menstrual phase, subjects were 
homogeneous in their level of pre-existing emotional distress and any between-group 
differences resulting from the affective manipulation cannot be attributed to pre-existing 
differences distress. 
Affective Manipulation 
Self-Report 
 To assess the impact of the noise stressor, 2 x 3 ANOVAs were conducted on 
SAM valence and arousal scores entering Phase (Ovulation, Luteal, Follicular) and 
Stress (Stress, No Stress) as between-subject variables.  Figure 3 illustrates emotional 
Valence and Arousal scores to the presentation of the noise stressor.  For valence, there 
was a significant main effect for Stress, [F(1, 34) = 30.47, MSE = 98.74, p <  0.001].  
This effect indicates that subjects in the Stress condition experienced the affective 
manipulation as more unpleasant than subjects in the No Stress condition.  Although 
there was not a significant Stress x Phase interaction [F(2, 34) = 17.55, MSE = 8.78, p = 
0.08], an exploratory pairwise comparison indicated that subjects in the Luteal phase 
who did not receive the noise stressor experienced the experiment as more unpleasant  
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Figure 3: Self-Reported SAM Valence and Arousal Ratings of 
Stress.  A significant main effect for stress was found for both 
valence and arousal in SAM ratings.  Subjects rated the noise 
stressor as significantly more unpleasant and arousing than those 
subjects who did not receive the noise stressor (p < 0.001).  There 
were no significant findings by phase. 
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than subjects in either the Ovulation or Follicular who also did not receive the noise 
stressor (ps < 0.05).    Analysis of arousal ratings indicates a significant main effect for 
Stress, [F(1, 34) = 65.29, MSE = 206.90, p < 0.001].  This finding implies that the 
subjects in the Stress condition experienced the noise stressor as more arousing than 
those in the No Stress condition.  Neither Phase differences nor interactions between 
Stress and Phase were found for either measure. 
A series of 2 x 3 ANOVAs were conducted on each of the verbal affective 
descriptors using Phase (Ovulation, Luteal, Follicular) and Stress (Stress, No Stress) as 
between-group variables.  Table 1 illustrates means and standard deviations for self-
reported affect to the noise stressor.  Significant main effects for condition were found 
for:  fear [F(1, 32) = 27.21, MSE = 29.81, p < 0.001], surprise [F(1, 33) = 43.07, MSE = 
49.29, p < 0.001], anxious [F(1, 33) = 13.19, MSE = 18.53, p < 0.001], happy [F(1, 33) 
= 7.51, MSE = 9.33, p < 0.01], relaxed [F(1, 33) = 8.64, MSE = 10.79, p < 0.01], 
disgusted [F(1, 33) = 4.43, MSE = 4.43, p < 0.01], and anger [F(1, 33) = 15.63, MSE = 
13.20, p < 0.001].  No significant findings for the affective descriptors, bored, neutral, 
and sad, were discovered.  Subjects in the Stress condition reported feeling more fearful, 
surprised, anxious, angry, disgusted, and less happy and relaxed, than those in the No 
Stress condition.  Although no significant interactions were found, a significant main 
effect for Phase was found for the anxiety descriptor, [F(2, 33) = 4.18, MSE = 5.87, p < 
0.05].  This finding suggests that those in the Follicular phase felt greater levels of 
anxiety when compared with those in other menstrual phases regardless of whether or  
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Table 1 
Means and Standard Deviations of Self-Reported Affective Response to the Noise Stressor 
 
 
Condition Fear  
1 - 5 
Surprise 
1 - 5 
Anx 
1 - 5 
Hap 
1 - 5 
Relax 
1 - 5 
Disgust 
1 - 5 
Anger 
1 - 5 
Bored 
1 - 5 
Neutrl 
1 - 5 
Sad 
1 - 5 
           Stress             M            
                      
                      SD 
2.28** 
 
1.36 
 
3.47**
 
 
1.07 
2.84**  
 
1.21 
0.79* 
 
0.79 
0.68* 
 
1.11 
0.74* 
 
1.10 
1.26** 
 
1.28 
0.79 
 
1.13 
0.68 
 
0.82 
0.47 
 
0.84 
 
          
 
          No Stress       M  
                             
                      SD                                  
0.35**  
 
0.75
0.90** 
 
1.17
1.45**  
 
1.40 
1.70* 
 
1.34 
1.80* 
 
1.20 
0.00* 
 
0.00 
0.00**
 
 
 
0.00 
1.45 
 
1.47 
1.55 
 
1.32 
0.05 
 
0.22 
 
Note.  Below each scale is the range of potential scores.  Means are in each column and below them are standard deviations.   
Superscript ** specifies that means in the same column differ at p < 0.001.  Superscript * specifies that means in the same 
column differ at p < 0.01.
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not they were presented with the noise stressor.   There were no other significant 
findings by Phase.  Together, the affective descriptors and SAM valence and arousal 
results suggest that subjects experienced the noise stressor as stressful. 
Heart Rate 
Heart rate data were sampled in two ways, one by examining changes in heart 
rate over the length of the experiment and the other by analyzing heart rate during the 
noise stressor.  To begin, heart rate was recorded for a 1-min period prior to each set of 
pain tests and during the 2-min presentation of the noise stressor.  These samples were 
represented as beats-per-min (BPM) scores and analyzed using a mixed ANCOVA.  The 
1-min block of time prior to the noise stressor was entered in as a covariate.  The 2-min 
stress period pain and the 1-min block of time after the stressor were entered in as a 
repeated measures variable (Time), while Stress and Phase were entered in as between-
subjects variables.  After a Greenhouse-Geisser correction was made (ε = 0.84), there 
was a significant Time x Stress interaction [F(2, 40) = 7.79, MSE = 109.06, p < 0.01].  
Figure 4 depicts the impact of the stressor on heart rate.   
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Figure 4: The Impact of the Stressor on Mean Heart Rate. Subjects in the 
Stress condition demonstrate a significant decrease in their mean heart 
rate during the 2nd minute of the noise stressor (p < 0.05).  There are no 
differences in mean heart rate for subjects in the No Stress condition. 
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Mean comparisons revealed that this interaction was attributed to a deceleration of heart 
rate observed in the Stress condition during noise presentation.  In contrast, those in the 
No Stress condition did not show any significant fluctuations in heart rate.   
In addition to examining the impact of the stressor across the length of the 
experiment, there was a significant Stress x Phase interaction [F(2, 95) = 5.71, MSE = 
2141.94, p < 0.01].  Figure 5 depicts mean heart rate across the experiment.  Pairwise 
comparisons revealed that subjects in the Ovulation phase who were presented with the 
noise stressor had an overall lower mean heart rate during the length of the experiment, 
while subjects in the Luteal phase who were presented with the noise stressor had an 
overall higher heart rate during the length of the experiment (ps < 0.05).  Furthermore, 
subjects in the Luteal phase who did not experience the stressor demonstrated a lower 
mean heart rate when compared to those in either the Ovulation or Follicular phases who 
also did not experience the noise stressor (ps < 0.05).  Subjects in the Follicular phase 
demonstrated no differences in their mean heart rate.
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Figure 5: Mean Heart Rate (BPM) over the Length of the Experiment.  
There was a significant interaction between Stress and Phase.  
Subjects in Luteal phase who were presented the noise stressor 
demonstrate a significantly higher mean heart rate compared to those 
who did not receive the stressor (p < 0.05).  Subjects in the Ovulatory 
phase who received the stressor demonstrated significantly lower 
mean heart rate when compared to those who did not receive the 
stressor as well as subjects in the Luteal phase who received the 
stressor (p < 0.05).  There were no effects found in the Follicular 
phase. 
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To examine the direct effects of the noise stressor on heart rate, a second analysis 
was conducted that consisted of breaking the 2-min noise stress period into 5-sec blocks 
and examining the effect of the stressor on immediate heart rate.  Samples were analyzed 
using a mixed ANOVA, with the twenty-four 5-sec blocks being entered as a repeated 
measures variable (Time) while Stress and Phase were entered as between-subjects 
variables. After a Greenhouse-Geisser correction was made (ε = 0.37), there was a 
significant Time x Stress interaction [F(23, 575) = 2.93, MSE = 1.50, p < 0.001].  Figure 
6 depicts this heart rate during the presentation of the noise stressor.  Mean comparisons 
revealed that this interaction was attributed to subjects in the Stress condition 
demonstrating significant fluctuations in heart rate during the presentations of noise 
stress.  In contrast, those in the No Stress condition did not show significant fluctuations 
in heart rate. 
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Figure 6: Mean Heart Rate (BPM) across the Presentation of the Noise Stressor.  
Subjects in the Stress condition demonstrate significant decreases in mean heart rate 
after presentations of the noise stressor (p < 0.05).   
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In addition to examining the fluctuations of heart rate during the length of the 2-
min presentation of noise stress, there was also a significant Stress x Phase cross-over 
interaction [F(2, 575) = 5.92, MSE = 57.66, p < 0.01].  Figure 7 depicts mean heart rate 
during the 2-min presentation of noise.  Pairwise comparisons revealed that subjects in 
the Ovulation phase who were presented with the noise stressor had an overall lower 
mean heart rate during the 2-min presentation of noise, while those in the Luteal phase 
who were presented with the noise stressor had an overall higher heart rate during 2-min 
presentation of noise (ps < 0.05).  This finding is similar to the significant interaction 
found when examining heart rate during the length of the experiment.  Together, both 
findings suggest that noise stress produces divergent autonomic effects across the 
menstrual cycle specifically between the Ovulation and Luteal phase.  In addition, this 
cross-over interaction demonstrates that those in the Luteal phase who did not receive 
the stressor had an overall lower mean heart rate during the 2-min affect manipulation 
compared to those in the Ovulation phase who did not receive the stressor who had an 
overall higher mean heart rate (ps < 0.05).  Those in the Follicular phase demonstrated 
no differences in their mean heart rate and there were no significant interactions between 
those in the Follicular phase and the other two phases.   
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Figure 7: Mean Heart Rate (BPM) during the Presentation of the Noise 
Stressor.  There was a significant interaction between Stress and Phase.  
Subjects in the Luteal phase demonstrated a significantly lower mean 
heart rate in the No Stress condition (p < 0.05).  Both the Ovulatory and 
Follicular phase demonstrated significantly decreased mean heart rate 
during the noise stressor (p < 0.05).  However, the Luteal phase 
demonstrated a significant increase in mean heart rate (p < 0.05).    
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Skin Conductance Level 
 Tonic skin conductance was sampled as a mean skin response level in 1-min 
blocks prior to the pain tests as well as during the 2-min presentation of noise stress.  
These tonic samples were analyzed using a mixed ANOVA with the blocks of time 
being entered into the analysis as a repeated measures variable (Time), while Stress and 
Phase were entered in as between-subjects variables.  After a Greenhouse-Geisser 
correction was made (ε = 0.59), there was a significant Time x Stress interaction [F(4, 
88) = 4.45, MSE = 2.84, p < 0.01].  Figure 8 depicts the skin conductance data over the 
length of the experiment.  Mean comparisons revealed that subjects presented with the 
noise stressor demonstrated significant increases in skin conductance, which suggests 
that the noise stress was autonomically stressful.  In contrast, those in the No Stress 
condition did not show any significant fluctuations in their level of skin conductance.  
There were neither any significant menstrual phase differences nor interactions found. 
Pain Reactivity and Secondary Hyperalgesia 
Spontaneous Pain 
VAS intensity and unpleasantness scores were analyzed using mixed ANOVAs 
with all five ratings used as a within-subject variable (Time) and Phase as a between-
subject variable.  Because the assumption of sphericity was not met, the Greenhouse-
Geisser correction was used for both intensity (ε = 0.45) and unpleasantness (ε = 0.39).  
A significant effect was found for time in both intensity [F(4, 136) = 38.52, MSE = 
6740.20, p < 0.001] and unpleasantness [F(4, 136) = 29.19, MSE = 6102.03, p < 0.001]. 
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Figure 8:  Mean Skin Conductance Level Across the Experiment.   
Figure 8: Mean Skin Conductance Level across the Experiment.  
Subjects in the Stress condition demonstrated a significant increase in 
their mean skin conductance level during the noise stressor (p < 0.05).  
There were no differences in mean skin conductance for subjects in the 
No Stress condition.   
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 Figure 9 depicts the VAS scores for the five 5-min rating periods during the 25-min 
period following capsaicin application, but before the noise stress manipulation.     
Pairwise comparisons indicated that reports of spontaneous pain during the first time 
period were significantly lower than the other time points (p < .05).  Furthermore, the 
second time period was significantly different time periods three, four, and five (p < 
.05).  No significant differences were found for Phase.  This finding suggests that the 
capsaicin manipulation produced a significant spontaneous pain response that indicates 
the presence of secondary hyperalgesia.  Two additional simple ANOVAs were 
conducted in hope of examining the role of Phase in spontaneous pain.  The first 
ANOVA examined the impact of Phase on mean VAS ratings for intensity [F(2, 34) = 
0.06, MSE = 31.58, p = 0.94] and unpleasantness [F(2, 34) = 0.30, MSE = 192.90, p = 
0.74], but they were not significant.  The second ANOVA examined the impact of Phase 
on the slopes of VAS ratings for intensity [F(2, 34) = 0.50, MSE = 12.56, p = 0.61] and 
unpleasantness [F(2, 34) = 1.12, MSE = 37.67, p = 0.34], but again no significant 
findings were discovered.           
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Figure 9: VAS Pain Ratings during Capsaicin 
Application.  There was a significant time effect 
for both the pain dimensions of Intensity and 
Unpleasantness (p < 0.001).  There were no 
interactions or main effects for Phase.   
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Secondary Hyperalgesic Pain 
Before examining the impact of the affective manipulation on secondary 
hyperalgesic pain, the area of secondary hyperalgesia needed to be recorded for each 
subject.  To document this area, each spoke along the grid was examined beginning from 
the center and radiating outward.  The boundaries of secondary hyperalgesia were 
decided using previously published methodology (Huang, et al., 2000). Specifically, a 
boundary was defined as a 50% reduction in pain ratings for a given site relative to the 
previous site on the spoke.  Once the area of secondary hyperalgesia was documented, 
the average pain rating along each spoke within the secondary hyperalgesic zone was 
calculated.   
To examine the impact of the affective manipulation on secondary hyperalgesic 
pain, change from pre-stress scores were calculated along each spoke.  Figure 10 depicts 
changes in post-stress VAS ratings from pre-stress VAS ratings.  Change scores were 
analyzed using a 2 x 3 ANOVA with Stress and Phase being entered in as between-
subjects variables.  Although the Stress x Phase interaction was not significant [F(2, 31) 
= 2.69, MSE = 0.33, p = 0.08], an exploratory pairwise comparison indicated that only 
subjects in the Luteal phase demonstrated affective pain modulation (p < 0.05), 
specifically greater hyperalgesia.  There were no other effects by either Phase or Stress.  
However, there is a non-significant trend where subjects in the Luteal phase who did not 
experience the noise stressor demonstrated greater decay of allodynia over the 
experiment.  This is evidenced by these subjects’ lower pain ratings to the allodynia  
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Figure 10: Change in Mean Pain Ratings of 
Secondary Hyperalgesia.  Although there 
were no significant findings in pain ratings 
by phase or stress, an exploratory Pairwise 
comparison of the Luteal phase demonstrates 
greater hyperalgesia (p  < 0.05).  No other 
significant exploratory Pairwise comparisons 
were found. 
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during the post-stress pain test when compared to the means of subjects in the Ovulation 
and Follicular phases who also did not experience the noise stressor. 
Area of Secondary Hyperalgesia 
 First, to examine the impact of menstrual phase on area of secondary 
hyperalgesia an analysis was conducted with the pre-stress pain test.  An ANOVA was 
used with Phase being entered in as a between-subject variable.  No significant Phase 
effects on pre-stress secondary hyperalgesia were found, [F(2, 37) = 0.32, MSE = 
2632.95, p = 0.73].   Figure 11 illustrates the impact of the noise stress on the area of the 
secondary hyperalgesic zone.  A change score was calculated by subtracting the post-
stress area score from the pre-stress area score.  A 2 x 3 ANOVA was used to analyze 
the area of secondary hyperalgesia, with Stress and Phase being entered in as between-
subjects variables.  A significant Stress x Phase interaction emerged [F(1, 31) = 3.47, 
MSE = 4482.70, p < 0.05].  Pairwise comparisons indicated that subjects in the Luteal 
phase demonstrated significantly greater secondary hyperalgesia after the presentation of 
the noise stressor (p < 0.01).  Subjects in both the Menstrual and Follicular phase failed 
to demonstrate any significant changes in area of hyperalgesia.  Furthermore, pairwise 
comparisons also demonstrated that subjects in the Luteal phase also demonstrated 
significantly greater decay of secondary hyperalgesia over the course of the experiment 
(ps < 0.05).  Specifically, subjects in the Luteal phase who did not experience the noise 
stressor demonstrated significantly greater decreases in the area of secondary 
hyperalgesia when compared to those subjects in the Menstrual and Follicular phases 
who also did not experience the noise stressor.  
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Figure 11: Change in Area of Secondary 
Hyperalgesia.  Subjects in the Luteal phase 
demonstrated a significantly greater area of 
secondary hyperalgesia after the presentation 
of the noise stressor (p < 0.05).  Subjects in the 
Luteal phase who did not experience the 
stressor demonstrated greater decay of 
secondary hyperalgesia than those in the 
Ovulatory and Follicular phases (p < 0.05).  
There were no significant findings in either the 
Ovulatory or Follicular phases. 
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GENERAL DISCUSSION AND SUMMARY 
The present experiment was conducted to test the impact of both noise stress and 
the menstrual cycle on secondary hyperalgesia associated with inflammation from a 
topical application of capsaicin on the forearm.   Previous studies have examined the 
impact of stress on capsaicin-related spontaneous pain and inflammation (Lutgendorf, et 
al., 2000; Logan et al., 2001); however, no studies have examined the impact of stress on 
secondary hyperalgesia.  Furthermore, no study to date has either examined the role of 
the human menstrual cycle on inflammatory pain perception or the role of the human 
menstrual cycle on models of affective pain modulation.   
To summarize the findings of the current study, significant effects were observed 
primarily in the luteal phase.  To begin, those in the luteal phase who did not receive the 
noise stressor reported that the experiment was more unpleasant than those in the other 
phases.  Furthermore, they demonstrated less sympathetic arousal during the experiment 
but greater autonomic arousal during the noise stressor.  Participants in the luteal phase 
also demonstrated an analgesic/anti-inflammatory response evidenced by an observed 
decrease in secondary hyperalgesia for those that did not receive the noise stressor.  No 
such changes in pain perception were discovered in the ovulation and follicular phases.  
Finally, in response to the noise stressor, an inhibition of the analgesic/anti-inflammatory 
effects was observed in the luteal phase.  No such evidence of stress-induced pain 
modulation was discovered in the ovulation and follicular phases.  The relation of these 
findings to previous studies will be discussed.  Potential hypotheses regarding the nature, 
mechanisms of action, and relevance will be discussed as well.      
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Affect Manipulation 
The affect manipulation in these experiments was a noise stressor which has been 
shown in previous research to elicit a stress response (Grimes et al., 2004; Rhudy & 
Meagher, 2001).  In the present study, subjects exhibited a stress response to the 
presentation of the noise stressor.  Specifically, subjects reported feeling significantly 
more unpleasant, excited, fearful, surprised, anxious, disgusted, and angry after being 
presented with the noise stressor and significantly more happy and relaxed when told 
they would not receive the stressor.  In terms of self-report, the only effect that emerged 
by phase suggested that those in the luteal phase viewed the prospect of receiving the 
noise stressor as significantly more unpleasant than the other phases, evidenced by 
higher unpleasantness ratings in those in the luteal phase that did not received the noise 
stressor.     
Heart rate was also monitored and recorded at specific times throughout the 
experiment to evaluate whether the affect manipulation altered sympathetic arousal.  A 
significant deceleration of heart rate occurred during the stress period followed by an 
acceleration of heart rate after the stress period.   Subjects who were not presented with 
the stressor did not demonstrate this heart rate response.  This deceleration-acceleration 
pattern has been observed in previous studies examining the impact of both noise and 
electrical shock stressors (Rhudy & Meagher, 2001; Rhudy & Meagher, 2000; Grimes et 
al., 2003; Grimes et al., 2004).  According to Lacey and Lacey’s (1979) intake-rejection 
hypothesis, heart rate deceleration is a response to the organism becoming more 
hypervigilant (intake) to its surroundings while the heart rate acceleration is a response 
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to the organism rejecting the stimulus as threatening.  Hence, the presentation of the 
stressor created a hypervigilance with the subjects orienting their attention to more 
possible stressors.  Once the subjects had not received a stressor for a period of time 
their hypervigilance subsided and attention diverted which caused their heart rate to 
begin to accelerate back to baseline.           
A cross-over effect was discovered between the luteal and ovulation phases in 
that they displayed divergent effects in their mean heart rate during the presentation of 
noise.  Specifically, the luteal phase demonstrated a high heart rate during the stressor 
and a low heart rate in the absence of the stressor, while the ovulation phase 
demonstrated a low heart rate during the stressor and a high heart rate in the absence of 
the stressor.  This finding for those receiving the stressor is consistent with other 
literature examining menstrual cycle effects on autonomic arousal where those in a pre-
menstrual group (analogous to the luteal phase) were observed to have lower heart rate 
than those in an inter-menstrual group (inclusive of both the follicular and ovulation 
phases) (Kuczmierczyk & Adams, 1986).   
The manner in which subjects responded to the noise stressor was dependent on 
the specific menstrual phase in which they were tested.  Both those in the ovulation and 
follicular phase produced lower mean heart rates during the stressor compared to those 
in the luteal phase who produced a higher mean heart rate during the stressor.  This 
pattern of results suggests that those in the luteal phase were significantly more 
autonomically aroused at the prospect of a negative stressor.  And although subjects in 
different menstrual phases did not report the stressor as significantly more or less 
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stressful, the luteal phase is typically highly correlated with increased level of negative 
affect (Bloch, et al., 2000; Rubinow, 1992) suggesting that during this phase women are 
more likely to perceive stressful events as more negative.   
In addition to heart rate, skin conductance levels were also collected throughout 
the experiment to evaluate whether the affect manipulation altered sympathetic arousal.  
A significant increase in skin conductance was observed during the presentation of the 
noise stressor.   Subjects who were not presented with the stressor did not demonstrate 
any change in their level of skin conductance.  Based on heart rate, skin conductance and 
self-report data, these findings suggest that the affect manipulation was successful with 
the greatest autonomic response to the stressor generated by those in the luteal phase..  
Although it is difficult to identify the exact emotion induced (i.e., fear or anxiety), it is 
clear that the presentation of the noise stressor induced a negative, stressful emotional 
state while the absence of the noise stressor induced a more positive, relaxed emotional 
state. 
Pain Reactivity 
Spontaneous Pain 
 Spontaneous pain VAS ratings for both intensity and unpleasantness were taken 
during the 25-min capsaicin application.  Subjects rated their spontaneous pain as 
increasingly more intense and unpleasant over the 25-min period, which suggests that 
the capsaicin produced an inflammation of the forearm.  We hypothesized that ratings to 
spontaneous pain would be dependent on the subject’s menstrual phase, however, no 
such effects were observed.  One possible explanation for this null finding is that the 
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concentrations of varying inflammatory agents (i.e., formalin, carrageenan) employ 
different pain pathways, with low concentrations producing central sensitization and 
high concentrations producing both central and peripheral sensitization (Kuba et al., 
2006; Yashpal & Coderre, 1998).  In comparison to other studies that utilize a capsaicin 
model, the current study’s 6% topical capsaicin application would best be considered a 
low concentration in that most other human studies utilize a 6-10% capsaicin that is 
intradermally injected into skin (Fillingim & Ness, 2000).  Therefore, it is a possibility 
that the lower intensity capsaicin model used in this study relies more on central than 
peripheral sensitization pathways, which may have lessened the immediate impact of 
hormones on increasing inflammation and spontaneous pain.  Approximately 11-min 
after removal of the topical capsaicin, changes in pain perception begin to occur in the 
luteal group without the impact of any affective manipulation.  Given these observations, 
it seems likely that there is the potential to discover phase-specific effects to spontaneous 
pain if measurements are taken for a longer duration.  In addition, perhaps if either a 
higher concentration capsaicin or an alternative delivery method of the capsaicin was 
incorporated, then an attenuation of spontaneous pain in the luteal phase would be 
observed, which would be similar to the findings in other studies examining the role of 
sex hormones in inflammatory response to tonic pain models in animals (Ji et al., 2005; 
Kuba et al., 2006; Ren et al., 2000). 
Secondary Hyperalgesia 
 To examine the impact of stress and menstrual phase on secondary hyperalgesia, 
the present study induced secondary hyperalgesia by the mechanical stimulation of a 
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firm von Frey hair on inflamed skin associated with the application of a topical 
capsaicin.  Effects on secondary hyperalgesia and modulation of this hyperalgesia were 
observed only in the luteal phase.  No significant findings were discovered in the 
ovulation and follicular phase.  
In examining secondary hyperalgesia, two measures were examined, change in 
VAS ratings and change in the calculated area of secondary hyperalgesia.  Subjects in 
the luteal phase who did not experience the stressor demonstrated significant decay of 
secondary hyperalgesia over the length of the experiment when compared to both the 
ovulation and follicular phases.  Furthermore, those in the luteal phase demonstrated 
significantly greater secondary hyperalgesia after the presentation of the noise stressor.  
Specifically, it is likely that the stressor worked to inhibit the anti-inflammatory effects 
of progesterone to persistent inflammation, which is consistent with previous studies 
(Ren et al., 2000; Ji et al., 2005; Kuba et al., 2006).  As stated earlier, subjects in the 
luteal phase were significantly more sympathetically aroused to the noise stressor when 
compared to those in the ovulation and follicular phase, suggesting that they experienced 
the noise as more stressful.  This possible heightened susceptibility to negative affect 
during the luteal phase may explain why it was the only phase that demonstrated any 
pain modulatory effects.   
Given that the luteal phase is characterized by decreasing levels of estrogen and 
increases in progesterone, it is likely that progesterone-mediated effects are underlying 
the observed alterations in anti-nociception observed in the study.  Although 
progesterone appears to have the potential to alter both central and peripheral pain 
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transmission and modulatory systems (Fillingim & Ness 2000), it is unclear how 
progesterone may be modulating pain in the present study.  Peripherally, a potential 
hypothesis may be related to hormone-mediated effects at the level of the primary 
nociceptor and/or observed differences in autonomic arousal between menstrual phases.  
For example, sex hormones have been observed to impact pain modulation at the level of 
the primary nociceptor in that both chronically administered progesterone (Datta et al., 
1989) and pregnancy (Kaneko et al., 1994) have been observed to enhance the analgesic 
effects of local anesthetics in rats.  Furthermore, consistent with a previous study 
(Kuczmierczyk & Adams, 1985), subjects in the luteal phase who did not receive the 
stressor demonstrated lower mean heart rate than those in the ovulation and follicular 
phase.  And since previous studies have demonstrated the role of the noradrenergic 
system in potentiating capsaicin-induced hyperalgesia (Drummond, 1995; Chen & 
Levine, 2005) it is plausible that this overall lower sympathetic arousal in those that did 
not receive the stressor may have diminished secondary hyperalgesia while the higher 
sympathetic arousal in those that experienced the stressor may have maintained 
secondary hyperalgesia.  
Although this finding in the luteal phase may be related to peripheral 
sensitization and modulation, the attenuation of secondary hyperalgesia is also similar to 
the findings of other laboratories that progesterone has an anti-inflammatory/anti-
nociceptive effect in persistent inflammation models that appears to be centrally-
mediated (Ren et al., 2000; Ji et al., 2005; Kuba et al., 2006).  Multiple studies have 
described the impact of sex hormones on a variety of central pain transmission and 
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modulatory pathways (Fillingim & Ness, 2000).  For example, gonadal hormones appear 
to influence spinal NMDA receptors (Ren et al., 2000) as well as GABA receptors and 
levels of enkephalin in the periaqueductal gray (Smith et al., 1994), all of which play a 
significant role in centrally-mediated nociceptive processing.   
Hormonal effects have also been demonstrated in limbic regions, particularly the 
amygdala.  Walf and Frye (2003) demonstrated that intra-amygdala administration of 
estrogen and progesterone produces analgesia in rats, which suggests that the amygdala 
may be involved in hormone-mediated modulation of pain.  In relation to inflammatory 
pain, the use of naloxone after topical application of capsaicin has been shown to 
reactivate spontaneous pain, suggesting that the inhibition of capsaicin-related pain is 
suppressed by endogenous opioids along inhibitory pain modulatory pathways 
(Anderson et al., 2002).  This evidence together with a large body of research that 
demonstrates the significant role of the amygdala in affective processing and stress-
induced analgesia (e.g., Helmstetter, 1992; Helmstetter & Bellgowan, 1993), suggests 
that gonadal hormones have the propensity to produce centrally-mediated influences on 
affect and its modulation of pain.   
To further examine the hypothesis that sex hormones play a role in affective pain 
modulation, future studies should also be conducted to examine the impact of positive, 
calming affective manipulations on secondary hyperalgesia.  Perhaps a calming or 
positive affective manipulation may either enhance the analgesic effects of the luteal 
phase or even possibly impact the ovulation phase.  The potential to observe pain 
modulatory effects in the ovulation phase is particularly intriguing in that positive mood 
51 
                                                                                                                                                                        
 
                                             
states appear to be facilitated through estrogen-dependent serotonergic systems (Belthea 
et al., 1999; Derman et al., 1995). 
Summary 
In conclusion, although investigations into the role of sex hormones in pain, 
inflammation, emotion, and pain modulation have not always reported consistent 
findings along multiple lines of research, the results of the current study are consistent 
with past research that specifically examines the role of sex hormones in inflammation 
produced through tonic pain models.  Specifically, our results are consistent with prior 
studies indicating that progesterone has anti-inflammatory effects.  Although the 
specific mechanisms of this action still remain unclear, prior evidence points to the role 
of centrally-mediated pain modulation. Women in the luteal phase demonstrated 
greater sympathetic arousal during the stressor followed by a decrease in anti-
nociception.  It is likely that the stressor worked to inhibit the anti-inflammatory effects 
commonly observed in the luteal phase to persistent inflammatory pain through 
centrally-mediated pain modulatory mechanisms.  It is hypothesized that hormone-
mediated effects at the level of the amygdala influenced the impact of affective pain 
modulation.   
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